Log In
Print
BCIQ
Print
Print this Print this
 

Riboxxim

  Manage Alerts
Collapse Summary General Information
Company Riboxx GmbH
DescriptionToll-like receptor 3 (TLR3) agonist
Molecular Target Toll-like receptor 3 (TLR3)
Mechanism of ActionToll-like receptor 3 (TLR3) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Infectious (unspecified)
Indication DetailsTreat undisclosed infectious disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today